|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.9100 - 3.0500|
|52 Week Range||1.9200 - 8.5000|
|Beta (3Y Monthly)||7.75|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Keith Bliss of Cuttone and Company joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss Canopy Growth Corp (CGC), which begins trading on NYSE today and is the first pure cannabis play to achieve a listing on the exchange.
[Editor's note: This story was previously published in September 2018. It has since been updated and republished.] Investors are clamoring for ways to get in on a popular, but risky, marijuana-investing craze. Despite the reality that pot is illegal under federal law, many states have legalized the substance and plenty of marijuana ETFs have cropped up as a result. For recreational use, Oregon, Massachusetts, California and a few more states allow marijuana use. Yet, the majority of U.S. states have medical marijuana legislation in the pipeline. Presently, with the legal disconnect between federal and state law regarding marijuana use, investing directly in U.S. marijuana ETFs and stocks is risky and replete with scams and fraud. InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks That Won Super Bowl Sunday If you're determined to get in on the marijuana investing scene, there are several conservative-ish marijuana ETFs for partaking in the speculative pot party: ### Source: Shutterstock ### Alternative Harvest ETF (MJ) Hot off the New York Stock Exchange, the Alternative Harvest ETF (NYSEARCA:MJ) began trading on Dec. 26, 2017. Derived from an international real estate investment trust (REIT) fund, the marijuana ETF tracks cannabis cultivators, producers and distributors, along with cannabinoid drug makers, fertilizer producers and tobacco companies. As the first of what is sure to be many U.S. marijuana ETFs, the Alternative Harvest enjoys a first-mover advantage. ### Source: Shutterstock ### American Growth Fund (AMREX) It's risky to call American Growth Funds Series Two Class E (MUTF:AMREX) a conservative marijuana pick., as the fund has racked up significant losses in the past Yet, if you're a contrarian seeking a fund with access to the cannabis industry through marijuana ETFs you might consider AMREX. AMREX's top holdings include some well-known names and other niche pot players including GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Scotts Miracle-Gro Co (NYSE:SMG), Abbott Laboratories (NYSE:ABT), Cara Therapeutics Inc (NASDAQ:CARA), Cannabis Sativa Inc (OTCMKTS:CBDS) and more. * 7 Stocks That Won Super Bowl Sunday The fund is small and hasn't gained serious investor traction, but it might be a good diversifier against the movements of the S&P 500. ### Source: Shutterstock ### Cronos Group Inc. (CRON) Go north for another fund tapping into marijuana ETFs. Cronos Group (NASDAQ:CRON), formerly known as PharmaCan Capital Corp, and formerly trading on the OTC market under "PRMCF," is an investment firm focused on investing in the medical marijuana industry. Cronos' investments abide by Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Founded in 2013 in Toronto, the fund targets Canadian firms and makes minority investments in cannabis-related firms. ### Source: Shutterstock ### Create Your Own Pot Mutual Fund Diversification is key when investing in a speculative sphere like marijuana ETFs. You might want to dip your toes in the above marijuana ETFs and add in some popular cannabis-related stocks to round out your pot portfolio. M1 Finance and Motif both allow you to create your own mutual fund, for extremely low fees. You can choose the investments, purchase your preferred amount and voila, you have your own marijuana ETF, comprised of both funds and individual stocks! In addition to the funds profiled above, consider adding several pure marijuana industry stocks and pot-related holdings. Top marijuana stocks include Canopy Growth, Aphria Inc (OTCMKTS:APHQF) and GW Pharmaceuticals. Peripherally related pot stocks include Scotts Miracle-Gro or Constellation Brands, Inc. (NYSE:STZ). * 7 Stocks That Won Super Bowl Sunday Investing in marijuana is risky. With the disconnect between state and federal marijuana laws, putting your money in this sector sets you up for a roller coaster ride. Tread cautiously into the pot investing fields. Barbara A. Friedberg, MBA, MS is a veteran portfolio manager, expert investor, and former university finance instructor. She is editor/author of Personal Finance; An Encyclopedia of Modern Money Management and two additional money books. She is CEO of Robo-Advisor Pros.com, a robo-advisor review and information website. Additionally, Friedberg is publisher of the well-regarded investment website Barbara Friedberg Personal Finance.com. Follow her on twitter @barbfriedberg and @roboadvisorpros. As of this writing, she does not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 F-Rated Stocks That Could Break Your Portfolio * 5 Fintech Stocks to Buy As This Mega Trend Gains Steam * 10 Cold Weather Stocks to Heat Up Your Returns Compare Brokers The post 4 Best Marijuana ETFs for Conservative Portfolios appeared first on InvestorPlace.
MESQUITE, NV / ACCESSWIRE / February 4, 2019/ Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that PrestoDoctor founder Rob Tankson will be a featured guest at FASHINNOVATION, a platform where fashion and technology connect with a mission to inspire and share knowledge in the fashion, entrepreneurship and technology sectors, is hosting the second edition of its semi-annual conference on February 13, 2019. The all-day red carpet event takes place during NYFW at one of the city's premiere venues, Tribeca Rooftop, and features panels, live performances, installations, displays, and aims to "humanize homelessness" with the launch of a book titled: It Can Be You by The NYLON Project.
MESQUITE, NV / ACCESSWIRE / January 25, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that Virgin Mary Jane Brand http://virginmaryjanebrand.com will be among the most innovative companies ...
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With Congress approving the 2018 Farm Bill, stocks in the CBD space are poised to benefit and should run counter to the current market downward trends. The passage of the 2018 Farm Bill presents a tremendous opportunity for the CBD sector to continue to grow while the rest of the market shows significant volatility. Cannabidiol, or CBD, is the non-psychoactive chemical compound found in the hemp plant.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill. Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, “If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers.
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.
MESQUITE, NV / ACCESSWIRE / October 25, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension” to Cannabis Sativa”. The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage. “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014”, said President David Tobias.
Marijuana stocks, fueled by what may well be the biggest legal and medical revolution in years, have already proven they’re blazing their own trail. In all cases, though, there’s explosive potential on the table — the legal marijuana industry’s story has just gotten that compelling, as more states seek to legalize it while regulators finally start to see its legitimate medical benefits. Of all the marijuana stocks worth a look right now, Canopy Growth (NYSE:CGC) has garnered the most attention of late.
MESQUITE, NV / ACCESSWIRE / October 15, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that the United States Patent Office will issue to CBDS the US Patent number 10105343 titled "Cannabis based compositions and methods of treating hypertension" on October 23, 2018. "Cannabis Sativa made a bold deal acquiring this pending IP in the merger acquisition of Kush in 2014, which included Kubby Patent and Licenses. "This coconut oil based lozenge is unique because of its rapid onset and long term effects, and is based on our patented strain of cannabis, Ecuadorian Sativa", stated President David Tobias.
MESQUITE, NV / ACCESSWIRE / September 25, 2018 / Cannabis Sativa, Inc. (CBDS) subsidiary PrestoDoctor is pleased to announce that it is currently providing online medical marijuana recommendations to Pennsylvania residents via its HIPPA compliant trusted online recommendation platform https://Prestodoctor.Com/. PrestoDoctor makes the process simple and seamless by providing the state required two doctor appointments completely online, allowing patients to speak to licensed compassionate physicians who specialize in medical marijuana evaluations. Post appointment, PrestoDoctor provides patients all the necessary instructions on registering with the state in a comprehensive email.
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / U.S. equities retreated from records Monday as President Donald Trump plans to announce an additional $200 billion in tariffs on Chinese products. The Dow ...
Tilray (NASDAQ:TLRY) has made some lucky investors much, much richer than they were just a few weeks ago. Tilray stock is now up more than 500% from its July 19 IPO price, and up more than 350% for traders who bought it on the open market immediately following its initial public offering.
MESQUITE, NV / ACCESSWIRE / September 12, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, tops the High Times list of their first ever 'Women in Weed'' themed issue. Debby Goldsberry was lauded as an advocate and owner operator of Magnolia Oakland Dispensary. ''We congratulate Debby Goldsberry for her well-deserved top placement,'' said CEO and former Senator Mike Gravel, ''I am proud to have motivated Debby to come aboard Cannabis Sativa.
MESQUITE, NV / ACCESSWIRE / April 5, 2018 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that PrestoDoctor®, the leading online medical marijuana recommendation service, will be expanding ...